期刊文献+

高血压患者胰岛素抵抗及其与血脂的关系 被引量:4

Relationship Between Insulin Resistance and Serum Lipid in Patients With Hypertension
下载PDF
导出
摘要 目的:初步探讨高血压非糖尿病患者胰岛素敏感性及其与血脂水平的关系。方法:收集高血压患者82例,对照组76例,测定空腹胰岛素(FINS)浓度及空腹血糖(FPG),计算胰岛素敏感性指数(ISI);测定胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)和低密度脂蛋白胆固醇(LDL-C);测量身高、体重,计算体重指数(BMI)。结果:①高血压组较对照组FINS增高(21.39±14.21vs14.48±11.32,P<0.05),ISI降低(-4.59±0.52vs-4.18±0.54,P<0.05),TG升高(2.96±0.58vs1.30±0.50,P<0.05),HDL-C降低(1.30±0.07vs1.86±0.12,P<0.05)。②以ISI为因变量的多元逐步回归分析显示,影响因素为TG、SBP、BMI和HDL-C(r2=0.64,P<0.05)。结论:高血压患者更多存在胰岛素抵抗(IR)和血脂异常,IR与TG、SBP、BMI和HDL-C等因素密切相关。 Objective: To investigate the relationship between insulin resistance (IR) and serum lipid in patients with hypertension. Methods: Eighty-two patients with hypertension and 76 controls were included. Concentrations of fasting insulin (FINS) and fasting plasma glucose (FPG) were detected, and insulin sensitivity index (ISI) was calculated. Blood lipids (TC, LDL-C, HDL-C and TG), body height and weight were detected, and body mass index (BMI) was calculated. Results:① FINS(21.39± 14. 21 vs 14. 48±11.32,P〈0. 05) and TG (2. 96± 0. 58 vs 1.30± 0. 50,P〈0. 05) elevated; ISI ( -4. 59±0. 52 vs - 4. 18±0. 54,P〈0. 05) and HDL-C (1.30±0. 07 vs 1.86 ± 0. 12, P〈0. 05) decreased in patients with hypertension.② In a multiple linear step-wise regression analysis, with ISI as dependent variable and other factors as independent variables, TG, SBP, BMI and HDL-C were the main determinants for ISI(r^2 = 0. 64,P〈0. 05). Conclusions: Insulin resistance and dyslipidemia usually present in patients with hypertension. TG, SBP, BMI and HDL-C closely relate to IR in patients with hypertension.
作者 关伟
出处 《内科急危重症杂志》 2009年第3期143-145,共3页 Journal of Critical Care In Internal Medicine
关键词 高血压 胰岛素 血脂 体重指数 Hypertension Insulin Blood lipid Body mass index
  • 相关文献

参考文献8

  • 1崔永生,韩宗超,李斌.高血压心脑血管危险事件与胰岛素抵抗的关系[J].内科急危重症杂志,2000,6(1):13-14. 被引量:10
  • 2Nazzaro P, Triggiani R, Ciancio L, et al. Insulin resistance in essential hypertension: a psyehophysiological approach to the "chicken and egg" question. Nutr Metab Cardiovasc Dis, 2000, 10:275.
  • 3Sarafidis PA, Lasaridis AN. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome? J Cardiometab Syndr, 2008, 3:183.
  • 4Mather K, Anderson TJ, Verma S. Insulin action in the vasculature physiology and pathophysiology. J Vase Res, 2001, 38 : 415.
  • 5Holzl B, Iglseder B, Stadlmayr A, et al. Intima media thickness of carotid arteries is reduced in heterozygous carriers of the Gly972Arg variant in the insulin receptor substrate-1 gene. EurJ Clin Invest, 2003, 33: 110.
  • 6Guerre-Millo M, Gervois P, Raspe E, et al. Peroxisome proliferator activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem, 2000, 275: 16638.
  • 7Ide T, Shimano H, Yahagi N, et al. SREBPs suppress IRS mediated insulin signaling in the liver. Nat Cell Biol, 2004, 6: 351.
  • 8Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent obesity. Metabolism, 1990, 39: 167.

二级参考文献1

共引文献9

同被引文献67

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部